Landers J P, Winhall M J, McCready T L, Sanders D A, Rasper D, Nakai J S, Bunce N J
Department of Chemistry and Biochemistry, University of Guelph, Ontario, Canada.
J Biol Chem. 1991 May 25;266(15):9471-80.
The individual pretreatment of Sprague-Dawley rats with either 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) or 2,2',4,4',5,5'-hexachlorobiphenyl (HCB) has been previously shown to result in the "induction" of [3H]TCDD specific binding activity in hepatic tissue. In the present work, the coadministration of TCDD and HCB increased the concentration of hepatic proteins capable of binding [3H]TCDD specifically by at least 2-3-fold. This increase was shown not to be the result of activation, by HCB, of a form of the receptor having low affinity toward [3H]TCDD into a form with high affinity. Kinetic analysis of the time course of binding of [3H]TCDD to induced cytosol was consistent with the presence of an "inducible" binding protein in addition to the "constitutive" aryl hydrocarbon (Ah) receptor present in cytosol from untreated animals. The liganded ([3H]TCDD) form of the inducible binding component lost its ligand much faster than the liganded form of the constitutive Ah receptor at 37 degrees C; apparent first order rate constants for loss of [3H]TCDD were 0.55 min-1 and less than 0.0024 min-1, respectively. Conversely, the unliganded form of the induced binding component was slightly more stable (approximately 2-fold) toward thermal inactivation than the unbound constitutive Ah receptor. The [3H]TCDD-bound protein(s) in uninduced and induced cytosols behaved identically in a sucrose gradient; 8.7-8.9 S in the absence of salt, shifted to 5.5 S by 0.4 M KCl. They were also indistinguishable by gel permeation chromatography, and by photoaffinity labeling their TCDD-binding subunits, approximate molecular weights 105,000. These results show the hepatic TCDD-binding protein(s) induced upon pretreatment of Sprague-Dawley rats with TCDD/HCB to be kinetically distinct from the Ah receptor, but structurally very similar.
先前的研究表明,用2,3,7,8-四氯二苯并对二恶英(TCDD)或2,2',4,4',5,5'-六氯联苯(HCB)对Sprague-Dawley大鼠进行单独预处理,会导致肝组织中[3H]TCDD特异性结合活性的“诱导”。在本研究中,TCDD和HCB共同给药使能够特异性结合[3H]TCDD的肝蛋白浓度增加了至少2至3倍。结果表明,这种增加并非是由于HCB将对[3H]TCDD具有低亲和力的受体形式激活为具有高亲和力的形式所致。对[3H]TCDD与诱导的胞质溶胶结合的时间进程进行动力学分析,结果表明,除了未处理动物胞质溶胶中存在的“组成型”芳烃(Ah)受体外,还存在一种“可诱导”的结合蛋白。在37℃下,可诱导结合成分的配体化([3H]TCDD)形式比组成型Ah受体的配体化形式更快地失去其配体;[3H]TCDD丢失的表观一级速率常数分别为0.55 min-1和小于0.0024 min-1。相反,诱导结合成分的未配体化形式对热失活的稳定性比未结合的组成型Ah受体略高(约2倍)。未诱导和诱导的胞质溶胶中与[3H]TCDD结合的蛋白质在蔗糖梯度中的行为相同;在无盐情况下为8.7 - 8.9 S,在0.4 M KCl存在下转变为5.5 S。通过凝胶渗透色谱法以及对其TCDD结合亚基进行光亲和标记(近似分子量105,000),它们也无法区分。这些结果表明,用TCDD/HCB对Sprague-Dawley大鼠进行预处理后诱导的肝TCDD结合蛋白在动力学上与Ah受体不同,但在结构上非常相似。